Hydroxycitric Acid Tripotassium Hydrate Attenuates Monocrotaline and Hypoxia-Induced Pulmonary Hypertension in Rats
International Heart Journal · 2024
DOI: 10.1536/ihj.23-350 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Heart Journal, 2024. Verfasst von Shunjun Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Citrates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
This study investigated the effects of hydroxycitric acid tripotassium hydrate on right ventricular function, myocardial and pulmonary vascular remodeling in rats with pulmonary hypertension, and possible mechanisms. METHODS: Pulmonary hypertension was induced in male Sprague-Dawley rats by a single subcutaneous injection of monocrotaline or hypoxic chamber. In vivo, inflammatory cytokine (including TNF-α, IL-1β, IL-6, and TGF-β, the level of SOD) expression, superoxide dismutase and hydrogen peroxide levels, and p-IκBα and p65 expressions were detected. In vitro, pulmonary artery smooth muscle cell proliferation and migration, ROS production, and hypoxia-inducible factor-1 expression were also studied. RESULTS: Hydroxycitric acid tripotassium hydrate decreased right ventricular systolic pressure and reduced right ventricular fibrosis and pulmonary vascular remodeling in rats with two kinds of pulmonary hypertension. Moreover, the expression of both inflammatory and oxidative stress factors was effectively reduced, and the p65 signaling pathway was found to be inhibited in this study. Additionally, hydroxycitric acid tripotassium hydrate inhibited human pulmonary artery smooth cell proliferation and migration in vitro. CONCLUSIONS: This study shows that hydroxycitric acid tripotassium hydrate can alleviate pulmonary hypertension caused by hypoxia and monocycloline in rats, improve remodeling of the right ventricle and pulmonary artery, and inhibit pulmonary artery smooth muscle cell proliferation and migration. The protective effects may be achieved by regulating inflammation and oxidative stress through the p65 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-Sen University.
- Department of Thoracic Surgery, Qinghai Provincial Red Cross Hospital.
- Department of Pulmonary and Critical Care Medicine, Qinghai Provincial People's Hospital.
Zitieren
APA
Wang, S., Li, H., Liu, Q., Ma, H., Huang, L., Yu, L., & Wu, Z. (2024). Hydroxycitric Acid Tripotassium Hydrate Attenuates Monocrotaline and Hypoxia-Induced Pulmonary Hypertension in Rats. International Heart Journal. https://doi.org/10.1536/ihj.23-350
Vancouver
Wang S, Li H, Liu Q, Ma H, Huang L, Yu L, et al. Hydroxycitric Acid Tripotassium Hydrate Attenuates Monocrotaline and Hypoxia-Induced Pulmonary Hypertension in Rats. International Heart Journal. 2024. doi:10.1536/ihj.23-350
BibTeX
@article{Wang2024,
author = {Wang, Shunjun and Li, Huayang and Liu, Quan and Ma, Husai and Huang, Lin and Yu, Laishun and Wu, Zhongkai},
title = {Hydroxycitric Acid Tripotassium Hydrate Attenuates Monocrotaline and Hypoxia-Induced Pulmonary Hypertension in Rats},
journal = {International Heart Journal},
year = {2024},
doi = {10.1536/ihj.23-350}
}
EUVIMED